A Membrane‐Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis
Advanced Science · 2023-12 · 10 (35)
DOI: 10.1002/advs.202207736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.10.2023. Verfasst von Ming-Yu Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, TaiKang Center for Life and Me…. Hauptthemen laut MEDLINE: Candidiasis, Candidiasis, Vulvovaginal. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, Applied Basic Research of Sichuan Province.
Abstract (Originalsprache)
Candida albicans ( C. albicans ), a ubiquitous polymorphic fungus in humans, causes different types of candidiasis, including oral candidiasis (OC) and vulvovaginal candidiasis (VVC), which are physically and mentally concerning and financially costly. Thus, developing alternative antifungals that prevent drug resistance and induce immunity to eliminate Candida biofilms is crucial. Herein, a novel membrane‐targeted aggregation‐induced emission (AIE) photosensitizer (PS), TBTCP‐QY, is developed for highly efficient photodynamic therapy (PDT) of candidiasis. TBTCP‐QY has a high molar absorption coefficient and an excellent ability to generate 1 O 2 and •OH, entering the interior of biofilms due to its high permeability. Furthermore, TBTCP‐QY can efficiently inhibit biofilm formation by suppressing the expression of genes related to the adhesion ( ALS3 , EAP1 , and HWP1 ), invasion ( SAP1 and SAP2 ), and drug resistance ( MDR1 ) of C. albicans , which is also advantageous for eliminating potential fungal resistance to treat clinical infectious diseases. TBTCP‐QY‐mediated PDT efficiently targets OC and VVC in vivo in a mouse model, induces immune response, relieves inflammation, and accelerates the healing of mucosal defects to combat infections caused by clinically isolated fluconazole‐resistant strains. Moreover, TBTCP‐QY demonstrates excellent biocompatibility, suggesting its potential applications in the clinical treatment of OC and VVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, TaiKang Center for Life and Medical Sciences, Zhongnan Hospital of Wuhan University, School of Pharm…
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, 610031, China.
- Department of Respiratory Diseases, The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450014, China.
- Department of Medical Intensive Care Unit, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430070, China.
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
- Applied Basic Research of Sichuan Province
- Innovation Group Project of Natural Science Foundation of Hubei Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wu, M. Y., Xu, X., Hu, R., Chen, Q., Chen, L., Yuan, Y., Li, J., Zhou, L., Feng, S., Wang, L., Chen, S., & Gu, M. (2023). A Membrane‐Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis. Advanced Science, 10(35). https://doi.org/10.1002/advs.202207736
Vancouver
Wu MY, Xu X, Hu R, Chen Q, Chen L, Yuan Y, et al. A Membrane‐Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis. Advanced Science. 2023;10(35). doi:10.1002/advs.202207736
BibTeX
@article{Wu2023,
author = {Wu, Ming-Yu and Xu, Xiaoyu and Hu, Rui and Chen, Qingrong and Chen, Luojia and Yuan, Yuncong and Li, Jie and Zhou, Li and Feng, Shun and Wang, Lianrong and Chen, Shi and Gu, Meijia},
title = {A Membrane‐Targeted Photosensitizer Prevents Drug Resistance and Induces Immune Response in Treating Candidiasis},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {35},
doi = {10.1002/advs.202207736}
}
EUVIMED